Related Articles
The Legacy of Amyloid: Infiltration Linked to Dementia, Rheumatic Disease
An Unforgettable Story Her name was unforgettable. Not only did we share our given names—Simon and Simone, but her French-Canadian surname was based on this appellation, too. I was the junior resident working on our hospital’s nephrology service when she was admitted for evaluation of progressively worsening kidney disease and an overall failure to thrive….
With Genetic Testing Results, More May Be Better
(Reuters Health)—When people undergo genetic testing to find out whether they’re at risk for a specific disease, doctors often wonder how much information to give them. What if the genetic testing results reveal a risk for a disease the patient hadn’t been wondering about? Geneticists are “grappling with what to do with all the information…
New Osteoporosis Drugs Show Promise in Therapy Pipeline
Rheumatologists at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss medication alternatives to bisphosphonates that reduce bone resorption, build bone density and may provide new treatment options
The ACR’s Gout Guideline Co-Author Shares Insight on Treating Pain, Ongoing Patient Care
WASHINGTON, D.C.—Despite the value of guidelines, they often “are not read,” said N. Lawrence Edwards, MD, professor of medicine specializing in rheumatology at the University of Florida, at the 2016 ACR/ARHP Annual Meeting talk titled, New & Emerging Therapies for Gout, as part of the ACR Review Course. Or if they are read, they aren’t…